Multicancer early detection tests are among the priorities of the Biden administration’s Cancer Moonshot. The tests show promise, but questions remain about when and how to use them.
Academic rigor, journalistic flair
Articles on Biopsy
Displaying all articles
Early detection of breast cancer is critical to improving chances of survival. But racial and ethnic minority patients systematically have delayed diagnoses that reduce the benefits of screening.
Mistakes at the hands of health care providers are a major cause of death in the US. And many of the blunders are a byproduct of the system.
By measuring a cancer cell’s DNA in the bloodstream, scientists can get a snapshot of the cancer itself, which is referred as a “liquid biopsy”.
Top contributors
-
Post Doctoral Research Fellow in Melanoma, Edith Cowan University
-
Regents Professor, Arizona State University
-
Medical Fellow in Radiology, School of Medicine, University of Washington
-
Professor of Radiology, School of Medicine, University of Washington
-
Professor of Laboratory Medicine and Pathology, School of Medicine, University of Washington
